Typhus Fever Treatment Market Size & Share, by Type (Murine, Epidemic, Scrub Typhus); Treatment (Antibiotics, Pain Medication) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 3653
  • Published Date: Dec 04, 2023
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2024-2036

Typhus Fever Treatment Market size is estimated to cross USD 95 billion by the end of 2036, expanding around 10% CAGR during the forecast period i.e., 2024-2036. In the year 2023, the industry size of typhus fever treatment was over USD 55 billion. The growth of the market can be attributed to the increasing incidences of typhus fever across the globe Moreover, there has been a surging mortality rate if proper treatment is not taken at the right time. According to the data in 2019, scrub typhus may have a mortality rate of nearly 30 % if it is not treated early.

The lack of sanitation is another major factor responsible for the outbreaks of typhus fever, especially in underdeveloped countries. According to the data from the World Health Organization (WHO), 2 billion people globally do not have access to basic sanitation facilities, such as toilets, and 673 million people still defecate in the open. Furthermore, a lack of clean water and sanitation is set to drive the growth of this market in the future. Clean water and sanitation are essential for preventing typhus fever, However, many people in low and middle-income countries do not have access to these basic needs as a result they end up getting affected by this disease.

Typhus Fever Treatment Market
Get more information on this report: Request Free Sample PDF

Typhus Fever Treatment Sector: Growth Drivers and Challenges

Growth Drivers

  • Increasing Number of People Living in Crowded Areas - Housing overcrowding or people living in overcrowded conditions, is major factor estimated to boost the typhus fever treatment market growth. As per the data by Organization for Economic Co-operation and Development (OECD), a household is considered as overcrowded if less than one room is available in each household for every couple, individual above 18 years, and a pair of children below 18 years. Mexico is one of the most overcrowded countries in the world, with 33.191% of the population living in overcrowded households.
  • Growing Research and Development - It is possible that a number of new opportunities will be created in order to boost this typhus fever treatment market growth during the forecast period, due to an increase in R&D initiatives and favorable government support. Due to advances in treatment, pharmaceutical companies are making investments in research and development efforts on novel drugs and therapeutic approaches.
  • Presence of Well-Developed Healthcare Infrastructure - Owing to increasing urbanization and development in the healthcare domain the healthcare infrastructure all across the globe is advancing leading to the rise in the typhus fever treatment market in the projected period.


  • Increasing Emergence of Antibiotic-Resistant Strains - The medical community is increasingly worried about the emergence of antimicrobial-resistant strains of Salmonella typhi. The need to develop new and innovative treatment options for the fight against drug-resistant strains is therefore created. This is predicted to pose a restriction on the market expansion of typhus fever treatment in the upcoming time period.
  • Lack of Accessibility to Treatment is Predicted to Hamper the Market Growth in the Upcoming Period.
  • Unavailability of Vaccines on Large Scale for this Treatment are Set to Restrict the Market Growth in the Upcoming Future.

Typhus Fever Treatment Market: Key Insights

Base Year


Forecast Year

2024 - 2036



Base Year Market Size (2023)

~USD 55 billion

Forecast Year Market Size (2036)

~USD 95 billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Typhus Fever Treatment Segmentation

Type (Murine Typhus, Epidemic, Scrub Typhus)

In terms of type, the scrub typhus segment in the typhus fever treatment market is set to hold the highest revenue share of 40% during the time period between 2023 - 2036. The significant rise in the cases of scrub typhus fever is expected to drive the market growth in the forecast period. Similarly, the growth in the market for scrub typhus treatment is also expected to be stimulated by rising cases of infections caused by bacteria as well as improved healthcare infrastructure. More than a million new cases are diagnosed each year, and it is estimated that more than 1 billion people worldwide are at risk of typhus.

Treatment (Antibiotics, Pain Medication)

Typhus fever treatment market from the antibiotics segment is set to hold the largest share by the end of 2036. This increase is due to increased efforts by governments and regulators to control and treat infectious diseases, further promoting the use of antibiotics in various healthcare settings. Furthermore, continued research and development efforts by pharmaceutical companies aimed at discovering new antibiotics and improving existing antibiotics will lead to the introduction of more effective and targeted treatments, thereby increasing the number of antibiotics on the market. Therefore, the segment's dominance is expected to strengthen. Additionally, global efforts to fight infectious diseases are expected to propel the growth of the antibiotics sector in the studied period.

Our in-depth analysis of the global typhus fever treatment market includes the following segments:


  • Murine Typhus
  •  Epidemic
  • Scrub Typhus


  • Antibiotics
  • Pain Medication

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Typhus Fever Treatment Industry - Regional Synopsis

North American Market Forecasts

The typhus fever treatment market in North America region is anticipated to hold the largest revenue share of 35% by the end of 2036. The growth of this market can be attributed on the back of increasing prevalence of typhus fever in the region backed by increasing cases of mite and bug infestation. Moreover, the market position is strengthened through the presence of prominent participants and their products. In order to ensure the availability for typhus of innovative and efficient treatments, these companies take an active part in research and development activities. Moreover, market growth is expected to be stimulated by investments and collaboration between key players as a result of restrictions on the use of antibiotics in treating typhus fever.

APAC Market Statistics

The Asia Pacific typhus fever treatment market is set to grow substantially by the end of 2036. The growth can be attributed to poor housing conditions, overpopulation, and lack of healthcare awareness. According to the statistics by the World Health Organization (WHO), around 827,000 people in low- and middle-income countries die due to inadequate sanitation. Rapidly improving medical infrastructure, increasing disposable income, the availability of highly advanced healthcare facilities, increased health spending, and government measures aimed at reducing mortality due to typhus are also factors contributing to regional growth. Furthermore, the growth prospects for the Asia Pacific typhus treatment market are expected to be much higher during the forecast period with increasing healthcare tourism in India and China.  

Research Nester
Typhus Fever Treatment Market Size
Get more information on this report: Request Free Sample PDF

Companies Dominating the Typhus Fever Treatment Landscape

    • Biogen, Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Glenmark Pharmaceuticals
    • Merck KGaA
    • Novartis AG
    • Sanofi-aventis Groupe
    • Teva Pharmaceutical Industries Ltd.
    • Boehringer Ingelheim International GmbH
    • Siemens Healthcare GmbH


In The News

  • ViiV Healthcare, collectively owned b GlaxoSmithKline plc, Pfizer Inc. and Shionogi announced approval of the U.S. Food and Drug Administration (FDA) for cabotegravir as an antiviral drug.
  • GlaxoSmithKline pic and Vir Biotechnology, Inc. to conduct the Phase 3 trial of sotrovimab antimicrobial drug.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 3653
  • Published Date: Dec 04, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The growing prevalence of disease and lack of sanitization are some of the major factors anticipated to drive the growth of typhus fever treatment market.

The market is anticipated to attain a CAGR of ~10% over the forecast period, i.e., 2024-2036.

The major players in the market are of Merck KGaA, Novartis AG, Sanofi-aventis Groupe, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH,, and others.

The antibiotic segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in North America is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Typhus Fever Treatment Market Report Scope

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying